Renhe Pharmaceutical Excellent card dan part of the package on No 1-year-old disabled identity

"Home has children, standing excellent card Dan", song endorsement of the Children's cold medicine is a household name.　　But if the child in the family is less than one year old, then it is not a regular card dan, but a ban on Youku. In May 2012, the State Administration of Medicine (FDA) announced a paper on the prohibition of non-prescription drugs containing amantadine hydrochloride for infants under one year of age, Jean Ren and Pharmaceuticals (000650) (000650). SZ) Direct suspension, and the sales of the good and the Dan are also directly affected.　　Just after the company announcement has been revised and the sales staff informed, after 8 months, the daily economic news reporter still in guangzhou many pharmacies are free to buy without a year old baby under the ban, it does not appear to have any effect. Yesterday (January 24), Renhe Pharmaceutical issued a clarification bulletin said, the company's products in strict accordance with the National Drug Administration approved the standard for production and sales, product manuals are also through the State administration of Medicine strict examination and approval, as long as the correct use of product specifications will not cause liver and kidney damage to children.　　But the announcement did not restore confidence in the market yesterday, benevolence and pharmaceutical shares fell 4.93%, closed to 5.59 yuan. One year old, "drug prohibition" can still be purchased at will the State administration of drug regulation on the revision of the non-prescription drug containing amantadine hydrochloride notice (National food Drug Supervision [2012]117) shows that, non-prescription drugs containing amantadine hydrochloride are prescribed according to the specification of "child medication" in the Manual of Amantadine hydrochloride preparation (OTC) Instructions for the modification of the ammonia Kim Huangmin granules for children only, child ammonia phenol amine granule, child compound paracetamol amine tablets, delete "attention" in "children under the age of 1 should be used under the guidance of", in the "taboo" to add "due to the lack of neonatal and 1 years old, the safety and efficacy of infants, data, This product is prohibited for newborns and infants under 1 years of age. "And the reporter learned from many pharmacies, the current children of cold medicine is more common child paracetamol and ammonia Kim Huangmin granules, which contains amantadine hydrochloride, which excellent Cardin, good dolls, sunflower combo is a well-known brand consumers. According to the above-mentioned bulletin of the FDA, the relevant enterprises have revised the products. Benevolence and medicine in the clarification of May 24 last year, said that the company has been required to revise the instructions, and sent professionals to the company's sales cooperation units to inform the instructions, and asked them to cooperate with the next level of distributors or terminal pharmacies to explain.　　Training Notes will also be provided to pharmacies in direct supply terminals. However, the corrective action of the relevant companies does not seem to work in the market.　　Reporters yesterday visited the peace Big pharmacy, Bao Zhi Tang, two Heaven Big Pharmacy, Sea King stars and other Guangzhou six pharmacies, found that there are four pharmacies to sell is still revised before the superior card Dan, two are revised after the new products.　　Bao Zhi Tang pharmacy salesman to the illness asked more detailed, she said currently suitable for a year old infants under the cold medicine is not much, it is best to use proprietary Chinese medicine or let the Doctor prescribe, Western medicine on the baby's liver and kidney side effects, it is best not to use. and other pharmacies for infant cold medicine sales more casual, reporter asked 10What cold medicine the baby should use two Heaven large pharmacy salesman to the reporter recommended Guizhou lark (002424) Child ammonia phenol Amine granule, and said excellent Cardin, good dolls and other brands of child paracetamol and Amantadine granule can also be taken, these drug manufacturers are different, but the role is the same. Reporters noted that the store for the sale of the excellent card is January 7, 2012 production, in the taboo is only written: severe liver and kidney dysfunction is disabled.　　Note In the instructions or: children under 1 years old should be used under the guidance of physicians.　　"Daily Economic news" reporter survey found that some pharmacies for infants under one year old can not use amantadine hydrochloride-containing over-the-counter drugs are not clear, parents are afraid to be more difficult to know, if the misuse of the purchase, the consequences, who should bear the responsibility?　　New and old products in the market coexistence of new and old versions of drugs in circulation at the same time, consumers should say to whom? The daily economic news reporter yesterday called the Jiangxi Provincial Bureau of Drug Administration, a staff member told reporters that the revised notice has already reached the enterprise, the usual drug revisions have a buffer period, the enterprise within the stipulated time can also be sold before the production of products.　　Reporters asked the Cardin and other products containing amantadine hydrochloride, the buffer period to the end of the time, the staff expressed unclear. Dong Jin, executive vice president of the International Food Packaging Association said to reporters that the relevant policy changes after the new and old products how to sell three kinds of possibilities. First, the new policy into effect before the production of products can still be sold, the second is the new policy before the commencement of the requirements of enterprises to stop production, and after the entry into force can not sell old products, the third is the new policy before the effective date of production can continue to sell, resulting in new and old products　　If the policy is not limited to time, it is usually done in a third way, that is, the old product can be sold normally during the shelf life. "In the shelf life can be normal sales to reduce the waste of resources, and related products in the security does not have too much problem." After all, the enterprise is in accordance with the requirements of production, you can not do anything to pursue the enterprise.　　The Golden Lion said that parents should know more about this information and buy medicine carefully to overcome the problem of asymmetric information.　　And the Jiangxi Provincial Bureau of Drug Administration of the registration section staff also think that before the production of excellent card Dan is in line with national standards of products, can not be easily prohibited, should be the pharmacy of the pharmaceutical division of Consumers to guide.　　From the last May 24 of benevolence and medicine notice can be learned, excellent Cardin 2011 sales revenue is 308 million yuan, accounting for the annual operating income of 13.95%, visible recovery or destruction before the cost of production will be higher. And from yesterday the notice of benevolence and medicine can be learned that the revised statement before the production of excellent card Dan is indeed in circulation in the market. Then the coexistence of old and new products is a fact, can only control the terminal flow. But Renhe Pharmaceutical Bulletin said to dealers, pharmacies, terminal sales personnel and training measures such as the strength of how, the reporter yesterday dozens of times to call Renhe pharmaceutical industry Dong Office Telephone, no answer. From the Reporter's field investigation and the media nearJapan's public reports, can be found in Guangzhou, Beijing, Hangzhou, Shenyang and other place can still buy the above products, sales staff for the ban is not clear. In 2012, he and the pharmaceutical industry fell by 7.79% on the first day of the card recovery after the suspension of the event (May 24). And in the Half-year report also revealed "poison capsule incident" and the company's products and the product and other adverse factors such as change in the company's performance caused the impact of the company's results in the three quarter is a sharp decline, The company's first three quarters of net profit is 103 million yuan, 163 million yuan, 171 million yuan, the growth rate is 40.82%, 12.08%,-18.57%.